Christodoula Kourtidou
Overview
Explore the profile of Christodoula Kourtidou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Georgianos P, Kourtidou C, Kontogiorgos I, Vaios V, Leivaditis K, Gossios T, et al.
Am J Cardiovasc Drugs
. 2025 Mar;
PMID: 40055303
Finerenone is a novel nonsteroidal mineralocorticoid receptor (MR) antagonist (MRA) with unique pharmacological properties that offer potent and selective blockade of the MR with a more favorable side effect profile...
2.
Zicarelli M, Greco M, Roumeliotis S, Lo Vasco M, Dragone F, Kourtidou C, et al.
Medicina (Kaunas)
. 2025 Feb;
61(2).
PMID: 40005438
Sarcopenia is exceedingly frequent in end-stage kidney disease (ESKD) patients on dialysis, including those undergoing peritoneal dialysis (PD), and is of multifactorial origin. MOTS-c is a mitochondrial-derived peptide that promotes...
3.
Georgianos P, Kourtidou C, Leivaditis K, Kollias A, Liakopoulos V
Expert Rev Clin Pharmacol
. 2025 Feb;
:1-4.
PMID: 39959955
No abstract available.
4.
Kourtidou C, Ztriva E, Kostourou D, Polychronopoulos G, Satsoglou S, Chatzopoulos G, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(12):399.
PMID: 39076671
Background: The triglyceride/glucose index (TyG) reflects insulin resistance and predicts the risk of acute ischemic stroke (aIS). However, it is uncertain if this index predicts the severity and outcome of...
5.
Kourtidou C, Tziomalos K
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38674147
Diabetic kidney disease (DKD) is both a frequent complication of diabetes mellitus (DM) [...].
6.
Georgianos P, Kourtidou C, Divani M, Liakopoulos V
Expert Opin Pharmacother
. 2024 Feb;
25(2):127-130.
PMID: 38407201
No abstract available.
7.
Kourtidou C, Georgianos P, Vaios V, Liakopoulos V
J Hum Hypertens
. 2023 Oct;
38(1):84-87.
PMID: 37794131
No abstract available.
8.
Kourtidou C, Tziomalos K
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760839
Patients with chronic kidney disease (CKD) have a higher risk ofboth ischemic and hemorrhagic stroke. This association appears to be partly independent from the higher prevalence of established risk factors...
9.
Kourtidou C, Rafailidis V, Varouktsi G, Kanakis E, Liakopoulos V, Vyzantiadis T, et al.
J Pers Med
. 2023 Mar;
13(3).
PMID: 36983717
Background: Sodium glucose co-transporter 2 (SGLT2) inhibitors reduce cardiovascular morbidity and delay the progression of kidney disease in patients with type 2 diabetes mellitus (T2DM). However, the mechanisms underpinning these...
10.
Kourtidou C, Tziomalos K
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36983082
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease. The pathogenesis of DKD is multifactorial, with several molecular pathways implicated. Recent data suggest that histone modification plays...